Technical Analysis for ALDR - Alder BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 13.41 8.50% 1.05
ALDR closed up 8.5 percent on Friday, January 18, 2019, on 2.11 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ALDR trend table...

Date Alert Name Type % Chg
Jan 18 MACD Bullish Centerline Cross Bullish 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Above Upper BB Strength 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 18 Up 5 Days in a Row Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%

Older signals for ALDR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Alder Biopharmaceuticals Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has completed Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; and Clazakizumab that has completed Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis. The company also has preclinical programs in the discovery phase for various indications. Alder Biopharmaceuticals Inc. has a collaboration with Bristol-Myers Squibb Company for the development of Clazakizumab. Alder Biopharmaceuticals Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.
Is ALDR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.869
52 Week Low 9.44
Average Volume 847,162
200-Day Moving Average 15.1342
50-Day Moving Average 11.9928
20-Day Moving Average 10.9235
10-Day Moving Average 11.323
Average True Range 0.8048
ADX 22.3
+DI 33.4002
-DI 12.455
Chandelier Exit (Long, 3 ATRs ) 11.0956
Chandelier Exit (Short, 3 ATRs ) 11.8544
Upper Bollinger Band 12.6435
Lower Bollinger Band 9.2035
Percent B (%b) 1.22
BandWidth 31.491738
MACD Line 0.1214
MACD Signal Line -0.2276
MACD Histogram 0.349
Fundamentals Value
Market Cap 908.04 Million
Num Shares 67.7 Million
EPS -5.14
Price-to-Earnings (P/E) Ratio -2.61
Price-to-Sales 1026.10
Price-to-Book 2.38
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.29
Resistance 3 (R3) 15.11 14.31 14.97
Resistance 2 (R2) 14.31 13.83 14.40 14.87
Resistance 1 (R1) 13.86 13.54 14.09 14.04 14.76
Pivot Point 13.06 13.06 13.17 13.15 13.06
Support 1 (S1) 12.61 12.58 12.84 12.79 12.06
Support 2 (S2) 11.81 12.29 11.90 11.95
Support 3 (S3) 11.36 11.81 11.85
Support 4 (S4) 11.54